DNAJC3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.950200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.659780E-01
Normal-vs-Stage2
5.065000E-01
Normal-vs-Stage3
3.180600E-01
Normal-vs-Stage4
3.183200E-01
Stage1-vs-Stage2
4.304400E-01
Stage1-vs-Stage3
5.160700E-03
Stage1-vs-Stage4
5.603800E-01
Stage2-vs-Stage3
6.810000E-02
Stage2-vs-Stage4
7.930200E-01
Stage3-vs-Stage4
9.963500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.325200E-01
Normal-vs-AfricanAmerican
1.340380E-01
Normal-vs-Asian
8.079800E-01
Caucasian-vs-AfricanAmerican
1.627550E-02
Caucasian-vs-Asian
4.835600E-01
AfricanAmerican-vs-Asian
3.197900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.973600E-01
Normal-vs-Female
4.953600E-01
Male-vs-Female
7.905800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.164800E-01
Normal-vs-Age(41-60Yrs)
3.078800E-01
Normal-vs-Age(61-80Yrs)
6.102400E-01
Normal-vs-Age(81-100Yrs)
6.772000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.693800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.959000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.482200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.600000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.766200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.617200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.291000E-01
Normal-vs-Daily Drinker
9.458400E-01
Normal-vs-Weekly Drinker
8.881400E-01
Normal-vs-Occasional Drinker
3.394600E-01
Normal-vs-Social Drinker
4.106600E-01
Non Drinker-vs-Daily Drinker
5.398800E-01
Non Drinker-vs-Weekly Drinker
8.959400E-01
Non Drinker-vs-Occasional Drinker
6.765600E-02
Non Drinker-vs-Social Drinker
1.430790E-01
Daily Drinker-vs-Weekly Drinker
6.996800E-01
Daily Drinker-vs-Occasional Drinker
3.094400E-02
Daily Drinker-vs-Social Drinker
6.836400E-02
Weekly Drinker-vs-Occasional Drinker
1.150990E-01
Weekly Drinker-vs-Social Drinker
1.927170E-01
Occasional Drinker-vs-Social Drinker
8.123000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.901410E-01
Normal-vs-Grade 2
3.066300E-02
Normal-vs-Grade 3
6.524200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.029800E-01
Grade 1-vs-Grade 3
8.681400E-01
Grade 1-vs-Grade 4
1.901410E-01
Grade 2-vs-Grade 3
9.223800E-01
Grade 2-vs-Grade 4
3.066300E-02
Grade 3-vs-Grade 4
6.524200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.220000E-01
Normal-vs-NonDiabetic
5.195200E-01
Diabetic-vs-NonDiabetic
4.557600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.407600E-01
Normal-vs-NoPancreatitis
5.193000E-01
Pancreatitis-vs-NoPancreatitis
3.919200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.248200E-01
Normal-vs-N1
4.890600E-01
N0-vs-N1
7.913400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.702800E-01
Normal-vs-TP53-NonMutant
4.759400E-01
TP53-Mutant-vs-TP53-NonMutant
8.347200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
